Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Vecht

Showing results (71-80 of 72) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 72 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972M J van den Bent, O Chinot, W Boogerd, et al.
Neurology|September 2, 2011
Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastomaM Weller, T Gorlia, J G Cairncross, et al.
Pageof 8

Showing results (71-80 of 72) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 72 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972M J van den Bent, O Chinot, W Boogerd, et al.
Neurology|September 2, 2011
Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastomaM Weller, T Gorlia, J G Cairncross, et al.
Pageof 8